Balance Sheet Dr. Lal PathLabs Limited

Equities

LALPATHLAB

INE600L01024

Healthcare Facilities & Services

Market Closed - NSE India S.E. Other stock markets 07:49:42 2025-07-11 am EDT			5-day change	1st Jan Change
2,926.50 ^INR	-0.10%		+2.72%	-2.46%

Jun. 25	Dr. Lal PathLabs Expands Genomics Capabilities with New Sequencing System	MT
Apr. 28	Nomura Adjusts Dr. Lal PathLabs' Price Target to INR3,560 From INR3,315, Keeps at Buy	MT

44dc2a2870cfbb3c76db1605da2c6f74.f1T-jhziLN2FgbGLkk8PD5-Z_EvbBYjzN5CHUIpUI2s.HCaaummFabfEsMK55DlAROnbswaVU-ChBPXmZtMgG1pKMar4WddksvK55A

Published financial data: DR. LAL PATHLABS LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	15.81B	20.87B	20.17B	22.27B	24.61B
Other Revenues, Total	-	-	-	-	-
Total Revenues	15.81B	20.87B	20.17B	22.27B	24.61B
Cost of Goods Sold, Total	7.05B	9.2B	8.92B	9.48B	10.37B
Gross Profit	8.77B	11.68B	11.25B	12.79B	14.24B
Selling General & Admin Expenses, Total	2.5B	3.47B	3.58B	4.14B	4.5B
Provision for Bad Debts	-	6.16M	36.47M	-	11.25M
Depreciation & Amortization - (IS)	772M	1.08B	1.5B	1.44B	1.42B
Other Operating Expenses	1.9B	2.57B	2.73B	2.54B	2.72B
Other Operating Expenses, Total	5.17B	7.13B	7.85B	8.11B	8.65B
Operating Income	3.6B	4.55B	3.4B	4.68B	5.59B
Interest Expense, Total	-160M	-302M	-375M	-294M	-223M
Interest And Investment Income	439M	473M	332M	554M	665M
Net Interest Expenses	279M	171M	-43.52M	261M	442M
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	16.52M	1.27M	1.02M	1.24M	22.35M
EBT, Excl. Unusual Items	3.89B	4.72B	3.36B	4.94B	6.06B
Gain (Loss) On Sale Of Investments	47.29M	31.62M	64.21M	104M	209M
Gain (Loss) On Sale Of Assets	-1.74M	-6M	8.07M	-2.18M	-21.51M
Other Unusual Items	5.42M	4.95M	6.96M	9.29M	3.35M
EBT, Incl. Unusual Items	3.94B	4.75B	3.44B	5.05B	6.25B
Income Tax Expense	979M	1.25B	1.03B	1.43B	1.33B
Earnings From Continuing Operations	2.96B	3.5B	2.41B	3.62B	4.92B
Net Income to Company	2.96B	3.5B	2.41B	3.62B	4.92B
Minority Interest	-48.58M	-54.58M	-22.29M	-45.58M	-51.14M
Net Income - (IS)	2.92B	3.45B	2.39B	3.58B	4.87B
Net Income to Common Incl Extra Items	2.92B	3.45B	2.39B	3.58B	4.87B
Net Income to Common Excl. Extra Items	2.92B	3.45B	2.39B	3.58B	4.87B
Per Share Items
Net EPS - Basic	35.33	41.7	28.82	43.05	58.48
Basic EPS - Continuing Operations	35.33	41.7	28.82	43.05	58.48
Basic Weighted Average Shares Outstanding	82.54M	82.69M	82.86M	83.11M	83.29M
Net EPS - Diluted	35.25	41.57	28.74	42.98	58.4
Diluted EPS - Continuing Operations	35.25	41.57	28.74	42.98	58.4
Diluted Weighted Average Shares Outstanding	82.74M	82.94M	83.12M	83.24M	83.42M
Normalized Basic EPS	28.89	35.01	25.07	36.63	44.83
Normalized Diluted EPS	28.82	34.9	24.99	36.57	44.77
Dividend Per Share	20	12	12	24	24
Payout Ratio	33.98	33.83	43.13	55.76	41.03
Supplemental Items
EBITDA	3.99B	5.19B	4.41B	5.67B	6.58B
EBITA	3.62B	4.78B	3.93B	5.21B	6.12B
EBIT	3.6B	4.55B	3.4B	4.68B	5.59B
EBITDAR	4.14B	5.45B	4.66B	5.94B	6.89B
Total Revenues (As Reported)	16.33B	21.4B	20.59B	22.96B	25.55B
Effective Tax Rate - (Ratio)	24.83	26.25	29.88	28.32	21.21
Total Current Taxes	1.02B	1.26B	1.08B	1.48B	1.72B
Total Deferred Taxes	-41.84M	-17.88M	-51.41M	-48.67M	-395M
Normalized Net Income	2.38B	2.89B	2.08B	3.04B	3.73B
Interest on Long-Term Debt	156M	199M	223M	200M	192M
Non-Cash Pension Expense	4.57M	4.65M	9.9M	13.74M	62.57M
Supplemental Operating Expense Items
Advertising Expense	307M	368M	508M	733M	778M
Selling and Marketing Expenses	307M	368M	508M	733M	778M
General and Administrative Expenses	2.04B	2.85B	2.82B	3.13B	3.42B
Net Rental Expense, Total	148M	261M	249M	272M	306M
Imputed Operating Lease Interest Expense	136M	184M	157M	192M	270M
Imputed Operating Lease Depreciation	12.69M	76.41M	91.94M	80.19M	35.93M
Maintenance & Repair Expenses, Total	338M	526M	683M	716M	735M
Stock-Based Comp., COGS (Total)	204M	323M	228M	217M	271M
Total Stock-Based Compensation	204M	323M	228M	217M	271M

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	2.44B	3.78B	2.64B	3.61B	2.93B
Short Term Investments	6.8B	2.38B	4.01B	4.68B	5.45B
Trading Asset Securities, Total	593M	655M	1.5B	1.14B	3.27B
Total Cash And Short Term Investments	9.84B	6.82B	8.14B	9.43B	11.64B
Accounts Receivable, Total	667M	854M	708M	774M	881M
Other Receivables	236M	199M	216M	315M	346M
Notes Receivable	9.31M	10.68M	13.64M	12.77M	11.24M
Total Receivables	912M	1.06B	938M	1.1B	1.24B
Inventory	426M	525M	338M	373M	361M
Prepaid Expenses	81.69M	139M	128M	164M	163M
Restricted Cash	1.43M	1.43M	-	-	-
Other Current Assets, Total	191M	205M	184M	202M	232M
Total Current Assets	11.45B	8.75B	9.73B	11.27B	13.64B
Gross Property Plant And Equipment	5.13B	-	7.79B	7.95B	8.61B
Accumulated Depreciation	-2.01B	-	-3.75B	-4.48B	-5.22B
Net Property Plant And Equipment	3.12B	4.3B	4.04B	3.47B	3.39B
Long-term Investments	-	-	-	-	-
Goodwill	854M	5.5B	5.48B	5.48B	5.48B
Other Intangibles, Total	595M	4.11B	3.58B	3.04B	2.51B
Loans Receivable Long-Term	700K	1.07M	560K	320K	40K
Deferred Tax Assets Long-Term	280M	370M	404M	449M	866M
Other Long-Term Assets, Total	312M	506M	620M	849M	1.28B
Total Assets	16.61B	23.53B	23.86B	24.56B	27.17B
Liabilities
Accounts Payable, Total	1.44B	1.47B	1.56B	1.87B	1.99B
Accrued Expenses, Total	229M	410M	405M	503M	567M
Short-term Borrowings	-	954M	700M	-	-
Current Portion of Long-Term Debt	-	834M	833M	833M	-
Current Portion of Leases	402M	481M	528M	606M	548M
Current Income Taxes Payable	49.44M	31.56M	4.97M	133M	138M
Unearned Revenue Current, Total	95.46M	94.92M	97.19M	117M	123M
Other Current Liabilities	526M	721M	567M	595M	658M
Total Current Liabilities	2.74B	5B	4.7B	4.65B	4.02B
Long-Term Debt	1.19M	1.67B	833M	-	-
Long-Term Leases	1.1B	1.39B	1.3B	1.03B	1.03B
Unearned Revenue Non Current	-	-	-	-	-
Pension & Other Post Retirement Benefits	-	-	-	-	19.47M
Deferred Tax Liability Non Current	7.55M	40.39M	29.41M	23.92M	33.73M
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	3.85B	8.1B	6.86B	5.71B	5.1B
Common Stock, Total	833M	833M	834M	835M	836M
Additional Paid In Capital	928M	928M	935M	1.05B	1.25B
Retained Earnings	10.52B	12.93B	14.53B	16.34B	20.05B
Treasury Stock	-200M	-162M	-119M	-144M	-195M
Comprehensive Income and Other	369M	554M	482M	410M	-216M
Total Common Equity	12.45B	15.08B	16.66B	18.49B	21.73B
Minority Interest	310M	355M	332M	361M	338M
Total Equity	12.76B	15.44B	17B	18.85B	22.06B
Total Liabilities And Equity	16.61B	23.53B	23.86B	24.56B	27.17B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	82.62M	82.76M	82.94M	83.21M	83.37M
ECS Total Common Shares Outstanding	82.62M	82.76M	82.94M	83.21M	83.37M
Book Value / Share	150.69	182.22	200.9	222.23	260.62
Tangible Book Value	11B	5.48B	7.6B	9.97B	13.74B
Tangible Book Value Per Share	133.16	66.17	91.66	119.79	164.76
Total Debt	1.5B	5.33B	4.19B	2.47B	1.57B
Net Debt	-8.34B	-1.49B	-3.95B	-6.96B	-10.07B
Debt Equivalent of Unfunded Proj. Benefit Obligation	54.45M	157M	188M	261M	231M
Debt Equivalent Oper. Leases	1.19B	2.08B	1.99B	2.17B	2.45B
Minority Interest, Total (Incl. Fin. Div)	310M	355M	332M	361M	338M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Others	426M	525M	338M	373M	361M
Land - (BS)	110M	-	110M	110M	110M
Buildings, Total	524M	-	554M	555M	555M
Machinery, Total	1.96B	-	3.05B	3.29B	3.62B
Full Time Employees	4K	4.11K	4.05K	4.1K	4.98K
Accumulated Allowance for Doubtful Accounts (Supple)	215M	285M	345M	315M	288M

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	2.92B	3.45B	2.39B	3.58B	4.87B
Depreciation & Amortization - CF	676M	780M	898M	834M	812M
Amortization of Goodwill and Intangible Assets - (CF)	25.15M	228M	532M	533M	532M
Depreciation & Amortization, Total	701M	1.01B	1.43B	1.37B	1.34B
Amortization of Deferred Charges, Total - (CF)	70.73M	73.35M	72.26M	68.25M	75.29M
(Gain) Loss From Sale Of Asset	1.74M	6M	-8.07M	2.18M	21.51M
(Gain) Loss on Sale of Investments - (CF)	-47.29M	-31.62M	-64.21M	-104M	-209M
Stock-Based Compensation (CF)	204M	323M	228M	217M	271M
Provision and Write-off of Bad Debts	51.26M	-6.96M	112M	7.18M	45.73M
Other Operating Activities, Total	-283M	-186M	46.92M	-140M	-791M
Change In Accounts Receivable	-204M	-180M	33.35M	-72.96M	-153M
Change In Inventories	144M	-99.83M	187M	-35.01M	11.75M
Change In Accounts Payable	269M	34.33M	92.27M	305M	123M
Change in Other Net Operating Assets	158M	78.42M	41.78M	161M	78.5M
Cash from Operations	3.98B	4.47B	4.56B	5.35B	5.69B
Capital Expenditure	-356M	-941M	-365M	-512M	-443M
Sale of Property, Plant, and Equipment	4.16M	16.47M	5.03M	8.76M	6.74M
Cash Acquisitions	-31.5M	-4.58B	-178M	-3.54M	-
Sale (Purchase) of Intangible assets	-240M	-3.82B	-80.51M	-62.67M	-95.8M
Investment in Marketable and Equity Securities, Total	-1.89B	4.33B	-2.56B	-147M	-3.17B
Other Investing Activities, Total	396M	496M	306M	473M	666M
Cash from Investing	-2.12B	-4.49B	-2.87B	-243M	-3.03B
Long-Term Debt Issued, Total	-	3.45B	-	-	-
Total Debt Issued	-	3.45B	-	-	-
Long-Term Debt Repaid, Total	-235M	-621M	-1.43B	-1.87B	-1.17B
Total Debt Repaid	-235M	-621M	-1.43B	-1.87B	-1.17B
Issuance of Common Stock	1.49M	1.38M	8.72M	34.88M	127M
Issuance of Preferred Stock	1.5M	-	-	-	-
Common Dividends Paid	-991M	-1.17B	-1.03B	-1.99B	-2B
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-991M	-1.17B	-1.03B	-1.99B	-2B
Other Financing Activities, Total	-162M	-304M	-379M	-311M	-297M
Cash from Financing	-1.39B	1.36B	-2.83B	-4.14B	-3.34B
Miscellaneous Cash Flow Adjustments	-	-10K	-	-	-
Net Change in Cash	476M	1.34B	-1.14B	972M	-683M
Supplemental Items
Cash Interest Paid	158M	304M	377M	294M	223M
Cash Income Tax Paid (Refund)	1.02B	1.3B	1.06B	1.32B	1.64B
Levered Free Cash Flow	2.96B	-637M	3.43B	4.14B	4.63B
Unlevered Free Cash Flow	3.06B	-449M	3.66B	4.33B	4.77B
Change In Net Working Capital	-429M	-66.53M	-252M	-324M	-126M
Net Debt Issued / Repaid	-235M	2.83B	-1.43B	-1.87B	-1.17B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	14.81	14.16	8.98	12.09	13.52
Return on Total Capital	17.23	16.23	10.15	13.76	15.55
Return On Equity %	25.45	24.85	14.9	20.21	24.06
Return on Common Equity	25.6	25.05	15.08	20.35	24.22
Margin Analysis
Gross Profit Margin %	55.43	55.94	55.78	57.44	57.86
SG&A Margin	15.8	16.64	17.74	18.57	18.29
EBITDA Margin %	25.22	24.86	21.88	25.48	26.73
EBITA Margin %	22.91	22.88	19.5	23.42	24.88
EBIT Margin %	22.75	21.78	16.87	21.02	22.72
Income From Continuing Operations Margin %	18.75	16.78	11.95	16.27	20
Net Income Margin %	18.44	16.52	11.84	16.07	19.79
Net Avail. For Common Margin %	18.44	16.52	11.84	16.07	19.79
Normalized Net Income Margin	15.08	13.87	10.3	13.67	15.17
Levered Free Cash Flow Margin	18.7	-3.05	17	18.61	18.82
Unlevered Free Cash Flow Margin	19.34	-2.15	18.16	19.44	19.39
Asset Turnover
Asset Turnover	1.04	1.04	0.85	0.92	0.95
Fixed Assets Turnover	5.15	5.63	4.84	5.93	7.17
Receivables Turnover (Average Receivables)	26.78	27.45	25.82	30.04	29.74
Inventory Turnover (Average Inventory)	14.16	19.34	20.66	26.65	28.25
Short Term Liquidity
Current Ratio	4.18	1.75	2.07	2.42	3.39
Quick Ratio	3.92	1.57	1.93	2.26	3.2
Operating Cash Flow to Current Liabilities	1.45	0.89	0.97	1.15	1.41
Days Sales Outstanding (Average Receivables)	13.63	13.3	14.14	12.18	12.27
Days Outstanding Inventory (Average Inventory)	25.77	18.87	17.67	13.73	12.92
Average Days Payable Outstanding	69.23	57.22	63.43	65.93	67.89
Cash Conversion Cycle (Average Days)	-29.83	-25.05	-31.62	-40.02	-42.69
Long Term Solvency
Total Debt/Equity	11.79	34.5	24.68	13.1	7.13
Total Debt / Total Capital	10.55	25.65	19.8	11.58	6.66
LT Debt/Equity	8.64	19.8	12.55	5.46	4.65
Long-Term Debt / Total Capital	7.73	14.72	10.07	4.83	4.34
Total Liabilities / Total Assets	23.19	34.41	28.76	23.23	18.78
EBIT / Interest Expense	22.49	15.07	9.06	15.95	25.07
EBITDA / Interest Expense	26.88	18.41	12.87	20.6	31.1
(EBITDA - Capex) / Interest Expense	24.65	15.29	11.9	18.86	29.11
Total Debt / EBITDA	0.35	0.96	0.87	0.41	0.23
Net Debt / EBITDA	-1.94	-0.27	-0.82	-1.15	-1.45
Total Debt / (EBITDA - Capex)	0.38	1.15	0.94	0.45	0.24
Net Debt / (EBITDA - Capex)	-2.11	-0.32	-0.88	-1.26	-1.55
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	18.86	32.01	-3.38	10.4	10.54
Gross Profit, 1 Yr. Growth %	15.71	33.21	-3.66	13.7	11.34
EBITDA, 1 Yr. Growth %	29.66	30.08	-14.96	28.56	15.98
EBITA, 1 Yr. Growth %	33.02	31.8	-17.63	32.57	17.45
EBIT, 1 Yr. Growth %	32.8	26.38	-25.19	37.63	19.47
Earnings From Cont. Operations, 1 Yr. Growth %	30.27	18.15	-31.18	50.28	35.87
Net Income, 1 Yr. Growth %	29.07	18.25	-30.74	49.78	36.17
Normalized Net Income, 1 Yr. Growth %	27.66	21.4	-28.25	46.55	22.68
Diluted EPS Before Extra, 1 Yr. Growth %	28.79	17.93	-30.86	49.55	35.88
Accounts Receivable, 1 Yr. Growth %	29.8	28.03	-17.06	9.29	13.85
Inventory, 1 Yr. Growth %	-25.28	23.46	-35.66	10.36	-3.15
Net Property, Plant and Equip., 1 Yr. Growth %	3.28	37.76	-6.01	-14.11	-2.22
Total Assets, 1 Yr. Growth %	20.88	41.65	1.65	2.95	10.62
Tangible Book Value, 1 Yr. Growth %	20.83	-50.23	38.83	31.11	37.8
Common Equity, 1 Yr. Growth %	20.55	21.12	10.97	10.98	17.49
Cash From Operations, 1 Yr. Growth %	40.25	12.19	2.09	17.39	6.27
Capital Expenditures, 1 Yr. Growth %	-24.54	164.61	-61.2	40.13	-13.43
Levered Free Cash Flow, 1 Yr. Growth %	46.94	-121.55	-637.82	20.91	12.22
Unlevered Free Cash Flow, 1 Yr. Growth %	45.01	-114.68	-916.05	18.18	10.67
Dividend Per Share, 1 Yr. Growth %	66.67	-40	0	100	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	14.63	25.26	12.94	3.28	10.47
Gross Profit, 2 Yr. CAGR %	11.3	24.15	13.29	4.66	12.51
EBITDA, 2 Yr. CAGR %	17.72	29.87	5.18	4.56	22.11
EBITA, 2 Yr. CAGR %	18.95	32.41	4.2	4.5	24.78
EBIT, 2 Yr. CAGR %	18.61	29.56	-2.77	1.47	28.23
Earnings From Cont. Operations, 2 Yr. CAGR %	21.61	24.06	-9.83	1.7	42.89
Net Income, 2 Yr. CAGR %	21	23.54	-9.5	1.85	42.81
Normalized Net Income, 2 Yr. CAGR %	13.91	24.49	-6.67	2.54	34.09
Diluted EPS Before Extra, 2 Yr. CAGR %	20.82	23.24	-9.7	1.68	42.55
Accounts Receivable, 2 Yr. CAGR %	11.95	28.91	3.04	-4.8	11.54
Inventory, 2 Yr. CAGR %	22.12	-3.96	-10.87	-15.74	3.38
Net Property, Plant and Equip., 2 Yr. CAGR %	38.12	19.28	13.79	-10.15	-8.36
Total Assets, 2 Yr. CAGR %	23.43	30.85	19.83	2.3	6.72
Tangible Book Value, 2 Yr. CAGR %	10.75	-22.45	-16.87	34.92	34.41
Common Equity, 2 Yr. CAGR %	14.75	20.84	15.69	10.97	14.19
Cash From Operations, 2 Yr. CAGR %	34.98	25.44	7.02	9.47	11.69
Capital Expenditures, 2 Yr. CAGR %	1.03	41.31	1.33	-26.26	10.14
Levered Free Cash Flow, 2 Yr. CAGR %	15.77	-43.73	7.66	155.01	16.26
Unlevered Free Cash Flow, 2 Yr. CAGR %	17.57	-53.86	9.44	210.55	14.15
Dividend Per Share, 2 Yr. CAGR %	82.57	0	-22.54	41.42	41.42
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	14.37	20.15	14.88	12.09	5.65
Gross Profit, 3 Yr. CAGR %	11.76	18.17	14.09	13.42	6.84
EBITDA, 3 Yr. CAGR %	15.63	21.7	12.78	12.46	8.24
EBITA, 3 Yr. CAGR %	16.09	23.09	13.03	12.91	8.65
EBIT, 3 Yr. CAGR %	15.87	21.15	7.88	9.17	7.14
Earnings From Cont. Operations, 3 Yr. CAGR %	19.96	20.45	1.94	6.91	12.01
Net Income, 3 Yr. CAGR %	19.54	20.08	1.87	7.05	12.21
Normalized Net Income, 3 Yr. CAGR %	13.94	16.35	3.6	8.48	8.86
Diluted EPS Before Extra, 3 Yr. CAGR %	19.19	19.85	1.64	6.83	12
Accounts Receivable, 3 Yr. CAGR %	17.46	17.07	11.29	5.08	1.05
Inventory, 3 Yr. CAGR %	15.9	22.57	-15.96	-4.29	-11.73
Net Property, Plant and Equip., 3 Yr. CAGR %	22.59	38	10.17	3.6	-7.58
Total Assets, 3 Yr. CAGR %	21.97	29.22	20.18	13.92	5
Tangible Book Value, 3 Yr. CAGR %	14.13	-15.17	-5.83	-3.24	35.87
Common Equity, 3 Yr. CAGR %	16.48	16.84	17.29	14.1	13.11
Cash From Operations, 3 Yr. CAGR %	26.42	26.91	17.12	10.37	8.39
Capital Expenditures, 3 Yr. CAGR %	-17.12	39.26	-8.15	12.89	-22.21
Levered Free Cash Flow, 3 Yr. CAGR %	40.58	-33.9	19.42	11.91	93.71
Unlevered Free Cash Flow, 3 Yr. CAGR %	41.92	-41.24	20.21	12.28	119.9
Dividend Per Share, 3 Yr. CAGR %	64.41	25.99	0	6.27	25.99
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	14.85	18	13.8	13.1	13.09
Gross Profit, 5 Yr. CAGR %	13.56	16.54	12.37	12.57	13.46
EBITDA, 5 Yr. CAGR %	14.19	17.35	11.33	14.53	16.42
EBITA, 5 Yr. CAGR %	14.4	17.78	11.18	15.29	17.59
EBIT, 5 Yr. CAGR %	14.67	16.67	8.02	12.85	15.6
Earnings From Cont. Operations, 5 Yr. CAGR %	17.35	17.62	7.02	12.56	16.68
Net Income, 5 Yr. CAGR %	17.15	17.4	6.95	12.43	16.61
Normalized Net Income, 5 Yr. CAGR %	14.02	14.54	5.2	10.62	14.86
Diluted EPS Before Extra, 5 Yr. CAGR %	17.14	17.01	6.66	12.22	16.37
Accounts Receivable, 5 Yr. CAGR %	12.94	15.36	11.47	7.78	11.39
Inventory, 5 Yr. CAGR %	24	24.02	4.34	5.51	-8.7
Net Property, Plant and Equip., 5 Yr. CAGR %	22.66	28.32	18.99	16.23	2.35
Total Assets, 5 Yr. CAGR %	21.59	27.81	21.11	17.63	14.6
Tangible Book Value, 5 Yr. CAGR %	19.58	-0.06	0.54	2.13	8.57
Common Equity, 5 Yr. CAGR %	19.67	20.42	16.16	14.36	16.04
Cash From Operations, 5 Yr. CAGR %	20.22	21.13	18.27	19.62	14.91
Capital Expenditures, 5 Yr. CAGR %	-4.22	17.74	-10.18	7.99	-1.23
Levered Free Cash Flow, 5 Yr. CAGR %	73.28	-13.58	26.35	13.43	18.14
Unlevered Free Cash Flow, 5 Yr. CAGR %	73.87	-19.49	27.91	14.37	17.75
Dividend Per Share, 5 Yr. CAGR %	52.19	31.95	21.67	31.95	14.87